๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

More targets, more pathways and more clues for mutant p53

โœ Scribed by Garritano, S; Inga, A; Gemignani, F; Landi, S

Book ID
120559449
Publisher
Nature Publishing Group
Year
2013
Tongue
English
Weight
447 KB
Volume
2
Category
Article
ISSN
2157-9024

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

p53: more research and more questions
p53: more research and more questions
โœ Braithwaite, A W; Prives, C L ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 77 KB
Transcriptional activities of mutant p53
Transcriptional activities of mutant p53: When mutations are more than a loss
โœ Ella Kim; Wolfgang Deppert ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 137 KB

## Abstract The dominant oncogenic properties of mutant p53 have been recognized as a phenomenon associated with tumor progression a long time ago, even before it was realized that the major function of wild type p53 is that of a tumor suppressor. Recent advances in this fascinating area in tumor c

The interaction topology of Mycobacteriu
The interaction topology of Mycobacterium tuberculosis genes response to capreomycin and novel clues for more drug targets
โœ Fei Zheng; Jianping Xie ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 677 KB

The resurgence of tuberculosis (TB) and emergence of multidrug-resistant TB (MDR-TB) are significant obstacles to stop TB treatment. Capreomycin (CPM) is regarded as an ideal second-line treatment for TB as well as for MDR-TB. However, the inexorable emergence of capreomycin resistant TB cases accen